Why the study?
What is the comparative efficacy and safety of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias?
What is the comparative efficacy and safety of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias?
This study compared the predicted efficacy and adverse effects of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias using serial testing.
Supports individualized antiarrhythmic selection via serial testing in ventricular tachyarrhythmias; extends comparative RCT evidence for seven agents.
Background The relative efficacies of various antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias are not well known. This study examined the effectiveness of imipramine, mexiletine, pirmenol, procainamide, propafenone, quinidine, and sotalol in patients with ventricular tachyarrhythmias who were enrolled in the Electrophysiologic Study versus Electrocardiographic Monitoring trial. Methods Patients were randomly assigned to undergo serial testing of the efficacy of the seven antiarrhythmic drugs by one of two strategies: electrophysiologic study or Holter monitoring together with exercise testing. The seven drugs were then tested for efficacy in random order in patients who were eligible to receive them. The frequencies of predictions of drug efficacy and of adverse drug effects during the initial drug titration were tabulated for all 486 randomized subjects. Patients received long-term treatment with the first antiarrhythmic drug that was predicted to be effective on the basis of drug t...
No takes yet. Share an insight, caveat, or question.
Jay W. Mason (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: